ES2053578T3 - Pirrolidinonas substituidas. - Google Patents

Pirrolidinonas substituidas.

Info

Publication number
ES2053578T3
ES2053578T3 ES87810045T ES87810045T ES2053578T3 ES 2053578 T3 ES2053578 T3 ES 2053578T3 ES 87810045 T ES87810045 T ES 87810045T ES 87810045 T ES87810045 T ES 87810045T ES 2053578 T3 ES2053578 T3 ES 2053578T3
Authority
ES
Spain
Prior art keywords
hydrogen
formula
substituted
rest
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87810045T
Other languages
English (en)
Spanish (es)
Inventor
William Dr Bencze
Wolfgang Dr Frostl
Max Dr Wilhelm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2053578T3 publication Critical patent/ES2053578T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
ES87810045T 1986-01-30 1987-01-26 Pirrolidinonas substituidas. Expired - Lifetime ES2053578T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH34686 1986-01-30

Publications (1)

Publication Number Publication Date
ES2053578T3 true ES2053578T3 (es) 1994-08-01

Family

ID=4184917

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87810045T Expired - Lifetime ES2053578T3 (es) 1986-01-30 1987-01-26 Pirrolidinonas substituidas.

Country Status (21)

Country Link
US (1) US4945092A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0236263B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS62185068A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR870007159A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE84033T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU599951B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1312081C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD260066A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3783247D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK47187A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2053578T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI870329A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3007411T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU202862B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE61100B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL81394A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO870374L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ219101A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH23078A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT84204B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA87650B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
US20040180925A1 (en) * 2000-12-27 2004-09-16 Kenji Matsuno Dipeptidylpeptidase-IV inhibitor
EP4101561A1 (de) 2021-06-08 2022-12-14 Meusburger Georg GmbH & Co. KG Zentriereinrichtung für ein formwerkzeug mit gleichzeitig tragenden wälzkörpereinheiten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
US4144246A (en) * 1976-11-15 1979-03-13 Parke, Davis & Company Pyrrolidineacetic acid esters
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
DE2757680A1 (de) * 1977-12-23 1979-06-28 Troponwerke Gmbh & Co Kg Neue 2-oxo-1-pyrrolidinessigsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts

Also Published As

Publication number Publication date
ATE84033T1 (de) 1993-01-15
EP0236263A2 (de) 1987-09-09
IE870230L (en) 1987-07-30
HU202862B (en) 1991-04-29
NZ219101A (en) 1990-03-27
IL81394A (en) 1991-08-16
DK47187D0 (da) 1987-01-29
JPS62185068A (ja) 1987-08-13
GR3007411T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-07-30
EP0236263B1 (de) 1992-12-30
JPH0558631B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-08-27
EP0236263A3 (en) 1989-04-19
PT84204A (en) 1987-02-01
ZA87650B (en) 1987-09-30
DE3783247D1 (de) 1993-02-11
KR870007159A (ko) 1987-08-17
AU599951B2 (en) 1990-08-02
AU6809787A (en) 1987-08-06
DK47187A (da) 1987-07-31
FI870329A0 (fi) 1987-01-26
US4945092A (en) 1990-07-31
NO870374L (no) 1987-07-31
HUT43058A (en) 1987-09-28
CA1312081C (en) 1992-12-29
PT84204B (pt) 1989-09-14
DD260066A5 (de) 1988-09-14
IE61100B1 (en) 1994-10-05
NO870374D0 (no) 1987-01-29
IL81394A0 (en) 1987-08-31
FI870329A7 (fi) 1987-07-31
PH23078A (en) 1989-04-10

Similar Documents

Publication Publication Date Title
ES2059335T3 (es) Derivados de pirido(3,2,1-ij)-1,3,4-benzoxadiazina, procedimiento para su obtencion, preparados farmaceuticos correspondientes y productos intermedios utilizables en el procedimiento.
AR245700A1 (es) Nuevos derivados de la 2-anilino-pirimidina como agentes antiparasitarios.
ES8103744A1 (es) Un metodo para la preparacion de derivados de ftalimidina
DK0687253T3 (da) Hidtil ukendte 4-aminopyridiner, fremgangsmåde til deres fremstilling samt lægemidler indeholdende disse forbindelser
ES2063153T3 (es) Amino-4 quinoleinas y naftiridinas, su procedimiento de preparacion y su aplicacion como medicamentos.
AR240909A2 (es) Derivados de 2-(2'-alquilbenzoil) -1,3-ciclohexanodiona, composicion que los comprende y procedimiento para prepararlo"
PE107999A1 (es) Derivados 3-amidinoanilina, inhibidores del factor x de coagulacion de la sangre activado e intermediarios de los mismos
BR0108974A (pt) 3-fenil-5-alcóxi-1,3,4-oxdiazol-2-onas substituìdas e seu uso para a inibição das lipases sensìveis a hormÈnios
ES2031510T3 (es) N-fenil-butenamidas con propiedades farmaceuticas.
ES8705408A1 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina.
ES2196308T3 (es) Derivado de 2-cianoiminoimidazol que inhiben la pde iv.
DE68910420D1 (de) Benzotriazolgruppenhaltiges Diorganopolysiloxan.
ES2044981T3 (es) Un proceso para la preparacion de nuevos derivados de 4(3h)-quinazolinona.
ES2099362T3 (es) Derivados de octahidrofenantreno.
ES2064057T3 (es) Unos derivados de 2-(aminoalquil)-5-(arilalquil)-1,3-dioxanos, su preparacion y su aplicacion en terapeutica.
ES2000456A6 (es) Procedimiento para preparar deirvados de acido eicosatriinoico-5,8,11 y utilizacion de estos en composiciones farmaceuticas y cosmeticas.
ES2058247T3 (es) 4-hidroxicinnolin-carboxamidas, su utilizacion y metodo de preparacion.
ES2058064T3 (es) Derivados de beta-carbolina sustituidos con fenoxi, su preparacion y su utilizacion como medicamentos.
KR880009964A (ko) 아릴피페라지닐-에틸(또는 부틸)-페닐-헤테로시클릭 화합물
ES2053578T3 (es) Pirrolidinonas substituidas.
ES2061680T3 (es) Acidos y esteres azetidinilquinolonacarboxilicos.
ES2078519T3 (es) Acidos hidroxamicos ciclicos y su uso.
ES2028877T3 (es) Un procedimiento para preparar un compuesto heterociclico.
ES2053061T3 (es) Derivado de aminobutanol y procedimiento para la preparacion de 3-pirrolidinol a partir de dicho derivado.
AR017097A1 (es) Compuestos de 2-(3h)-oxazolona, utiles como inhibidores selectivos de cox-2; procedimiento para preparar dichos compuestos y composiciones farmaceuticasformuladas con dichos compuestos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 236263

Country of ref document: ES